Clinical Trial Update: BONVIVA(Ibandronate) PMS(Post-marketing Surveillance )

View source ↗

Summary

A post-marketing surveillance update for Bonviva (ibandronate) in osteoporosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Status: COMPLETED